Zika disease scientists in mice have reduced by attacking a protein found in the mood of mosquitoes Aedes aegypti, the disease transmitters, which was published today in the journal Nature Microbiology.
The results offer an opportunity to improve immunization against this disease, saying researchers from Yale University in America who used antibodies from mice blood cut by these insects to confirm the result. .
Genetic testing of the mosquito proteins and the investigation of their effects on cell culture, as well as in bone-bones of Zika, has been characterized by genetic testing of a type. A protein called AgBR1 aggravated the disease.
In further trials, the scientists examined how blocking AgBR1 could affect Zika's disease by developing an antiserum that was sent to mice that had been eaten by a flavored mosquitoes.
They concluded that the antiserum on the Zika virus level in animals had been reduced over time and that it also provided partial protection against disease and death.
The head of the research, Erol Fikri, said in a statement "the ultimate goal is to develop a vaccine that is effective against the virus by having the salivary protein target."
They are therefore looking at researching an additional mosquito proteins to see if they have similar effects on the disease.
Currently there is no vaccine or treatment for Zika disease, which may include fever, rash, pain, red eyes and pregnant women who may be causing the development of the developing sexual fauna. T fetus.